Can a pill that blocks a brain protein ease Parkinson's without levodopa?
Disease control
Recruiting now
This trial tests an experimental oral medication called VG081821AC for people with early to mid-stage Parkinson's disease. The drug blocks a brain protein called the adenosine A2A receptor, which may improve movement symptoms without using levodopa. About 152 adults in China will…
Phase: PHASE2, PHASE3 • Sponsor: Zhejiang Vimgreen Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC